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Triple-negative breast cancer cellsPhosphoprotein enriched in astrocytes of 15kDa (PEA-15) is known to sequester extracellular signal-
regulated kinase (ERK) in the cytoplasm, inhibiting tumorigenesis of human breast cancer cells.
Here, we describe how PEA-15 expression affects the dephosphorylation of epidermal growth factor
receptor (EGFR) through endoplasmic reticulum (ER)–plasma membrane (PM) contacts in MDA-MB-
468, triple-negative breast cancer (TNBC) cells. The increased intracellular calcium concentration
resulting from increased cytoplasmic phosphorylated ERK facilitates movement of ER-anchored cal-
cium sensors to the PM. The driving force of trans-localization of calcium-dependent proteins
enhances the contact between the activated EGFR and ER-localized phosphatase, PTP1B.
Consequently, our ﬁndings suggest a mechanism underneath the facilitation of EGFR dephos-
phorylation by cytoplasmic PEA-15 expression inside TNBC cells, which may be one of the dynamic
mechanisms for down-regulation of activated EGFR in cancer cells.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Phosphoprotein enriched in astrocytes of 15kDa (PEA-15) is a
small protein ﬁrst characterized in brain astrocytes [1] and found
to be ubiquitously expressed in other human tissues [2–4].
Structurally, PEA-15 consists of an N-terminal death effector
domain and a C-terminal tail including two serine residues,Ser104 and Ser116, which serve as the sites of phosphorylation
by protein kinase C (PKC), CaMKII, and AKT. The crystal structure
of the PEA-15/extracellular signal-regulated kinase (ERK) 2 com-
plex provides an unambiguous insight into how PEA-15 can lead
to the enrichment of phopho-ERK1/2 in the cytoplasm [5]. PEA-
15 directly interacts with unphosphorylated and phosphorylated
ERK2 in a bipartite manner to regulate the phosphorylation of
ERK2, rather than just inhibiting it. PEA-15 is known to have tumor
suppressive function through blocking the nuclear translocation of
ERK by sequestration in the cytoplasmic compartment, consequen-
tially inhibiting cell cycle progression and tumor cell invasion of
various cancer cells, originating from ovary, breast and colon
[6–8]. Moreover, PEA-15 has been reported to have an anti-apop-
totic role accomplished through its regulatory phosphorylation
by PKC and protein kinase B/AKT activity, but this anti-apoptotic
function presents large differences according to cell type [1,9–11].
In particular, overexpression of PEA-15 impeded the tumorigenesis
of tumor-bearing mice, with tumors originating from the triple-
negative breast cancer (TNBC) cell line with a high level of
epidermal growth factor receptor (EGFR) expression [12].
In this study, we focus on the mechanism of EGFR down-
regulation by the anti-tumorigenic role of PEA-15 in MDA-
MB-468 cells, because EGFR overexpression happens more
1034 M. Shin et al. / FEBS Letters 589 (2015) 1033–1039frequently in TNBC patients and the activated EGFR is involved in
critical cellular processes, such as inhibition of apoptosis, cell
migration, cell growth, and angiogenesis of various cancer cells
[13,14]. Moreover, endoplasmic reticulum (ER)-anchored protein
tyrosine phosphatase PTP1B is already known to dephosphorylate
the activated EGFR through membrane contact [15,16], and several
recent studies explained that elevated intracellular calcium may
allow association of the ER and plasma membrane (PM) [17,18].
In addition, cytoplasmic retention of ERK1/2 by PEA-15 sequestra-
tion may contribute to the regulation of calcium-sensing proteins
[19,20], and has been suggested to improve long-term survival
when occurring in breast cancer patients [21]. Therefore, we sug-
gest that one of the possible mechanisms of EGFR down-regulation
is through expression of tumor suppressive PEA-15 due to
retention of phosphorylated ERK in the cytoplasmic compartment
of TNBC cells via ER–PM contact induced by changes of the
intracellular calcium environment.
2. Materials and methods
2.1. Cell lines and culture conditions
MDA-MB-468 cells, purchased from American Type Culture
Collection (ATCC), were cultured at 37 C and 5% CO2 inFig. 1. Cell viability and EGFR-phosphorylation after PEA-15 expression in TNBC cell lines
were transfected with PEA-15::pcDNA3.1 (PEA-15) or empty vector (Mock). Statistical val
⁄⁄P < 0.001). (B) Endogenous EGFR expression levels in three TNBC cell lines, MDA-MB-468
vector (). (C) Levels of phosphorylated EGFR in two TNBC cell lines, MDA-MB-468 and M
control throughout all Western analysis. (D) Wound healing assay in metastatic TNBC cel
Cell migration in the MDA-MB-436 monolayer was determined at 48 h after woundin
microscope with 20 objective. Images of ﬁxed positions in the wounds were taken with
was determined by outlining of the wound and measurement of the area using Image
treatment with siRNA for the PEA-15 gene (PEA-15 siRNA) or scrambled siRNA (Scram siR
50-AGGAAGACATCCCCAGCGAA-30 , Reverse; 50- CCATAGTGAGTAGGTCAGGACG-30) and G
CTTACTCCTTGGAGGCCATG-30). (F) Immunoblot analysis performed with anti-EGFR, ant
(PEA-15 siRNA) or scrambled siRNA (Scram siRNA) treated MDA-MB-468 cells.Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
10% (v/v) FBS containing 100 U/ml penicillin and 100 lg/ml strep-
tomycin. MDA-MB-436 cells, also purchased from ATCC, were cul-
tured under the same conditions in RPMI 1640 medium
supplemented with 10% (v/v) FBS containing 100 U/ml penicillin
and 100 lg/ml streptomycin. The MDA-MB-231 cell line was
obtained from the Korea Cell Line Bank and maintained under
the same conditions as the MDA-MB-436 cells. All cell culture
media and supplements were purchased from Invitrogen.
2.2. Cell transfection and cell viability assay
Approximately 1.0  105 cells were plated and the plasmids
were transfected using the FuGENE HD Transfection Reagent
(Promega), according to the manufacturer’s protocol. Cell prolifera-
tion was measured at the absorbance of 490 nm after incubation
for 1 h in Cell Titer 96 Aqueous One Solution (Promega) contain-
ing 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) solution.
2.3. Scratch wound healing assay
Cell Comb™ Scratch Assay (Millipore) was performed as per the
manufacturer’s instructions. Brieﬂy, cells in 10 ml growth medium. (A) Cell viability of TNBC cell lines using MTS assay after transfection for 48 h. Cells
ues for the MTS assay are expressed as means ± S.D. (n = 3; student’s t-test, ⁄P < 0.05,
, MDA-MB-231, and MDA-MB-436. Cells were transfected with PEA-15 (+) or empty
DA-MB-436, with or without PEA-15 transfection. b-Actin was used for the loading
ls. Cells were transfected with empty vector (Mock) or PEA-15::pcDNA3.1 (PEA-15).
g of the layer by scratching. Cells were placed under a Nikon TS100-F inverted
a Nikon digital camera mounted on the microscope. The wound area in each picture
J analysis software. (E) Gel images were obtained from cDNA ampliﬁcation after
NA) as a control. RT-PCR was performed using primers speciﬁc for PEA-15 (Forward;
APDH for normalization (Forward; 50- TTAGCACCCCTGGCCAAGG-30 , Reverse; 50-
i-pERK and anti-ERK after treatment with EGF (100 ng/ml) for 1 h in PEA-15 siRNA
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would yield a conﬂuent monolayer within 1–2 days after plating.
When the cells reached conﬂuence, the mediumwas removed from
the plate, and the teeth of the comb (Cell Comb™) were drawn
across the monolayer aligned with the guide groove of the plate.
The scratched monolayer was then washed 3 times with media,
after which 10 ml media was applied into the plate. After 48 h,
migration in the scratch wound was measured.
2.4. Immunoblot analysis
Cells were lysed at 4 C in lysis buffer (50 mM Tris–HCl, pH 8.0,
0.15 M NaCl, 1% (v/v) Non-diet P-40, and protease/phosphatase
inhibitor cocktail). Following 40 min of incubation on ice, protein
extracts were centrifuged at 15000g (12000 rpm) for 10 min
at 4 C. The protein quantity of the clariﬁed supernatant was mea-
sured by Bradford assay, after which the lysates were diluted with
SDS sample buffer (0.4 M SDS, 0.4 M Tris–HCl, 40 mM EDTA, 50%
glycerol, and bromophenol blue). Lysates were then separated by
SDS–PAGE and transferred to nitrocellulose membranes. The mem-
branes were blocked in tris-buffered saline containing 0.1% (v/v)
Tween 20 and 5% (w/v) non-fat dried milk, and then incubated
with the primary antibodies, anti-EGFR, anti-pY1045-EGFR, anti-
PEA-15, anti-PTP1B, anti-ERK1/2, and anti-pERK1/2, overnight at
4 C (Santa Cruz). Horseradish peroxidase-conjugated anti-rabbit
or anti-mouse IgG was used as the secondary antibody (Dako).
Immunoreactive protein was visualized by the chemiluminescence
protocol using SuperSignal West Pico Luminol/Enhancer Solution
(Thermo Scientiﬁc). Equal amount of protein loaded was evaluated
with anti-b actin antibody (Sigma).Fig. 2. PEA-15 sequesters phosphorylated ERK in the cytoplasm and increases intrace
compartment after cell fractionation using a subcellular extraction kit (Calbiochem). (B)
L123K. PEA-15 consists of a globular DED (death effector domain; colored red) and a C-
yellow. (C) Immunoblots after cellular fractionation, indicating mutant PEA-15 does not in
was carried out according to the manufacturer’s instructions (Invitrogen), and image
wavelength settings (excitation at 485 nm, emission at 520 nm). Scale bar, 20 lm. (E) Q
Statistical values are expressed as means ± S.D. (n = 3; student’s t-test, ⁄P < 0.05, ⁄⁄P < 0.02.5. In situ proximity ligation assay
A Duolink (Olink Biosciences) in situ proximity ligation assay
(PLA) was performed following the manufacturer’s instructions
and our previous report. Brieﬂy, cells were ﬁxed with ice-cold
100% methanol for 20 min at 20 C and then washed twice with
PBS. Fixed cells were incubated in 10% bovine serum in PBS for
1 h at room temperature (RT) and then with the two primary
antibodies, anti-stromal interaction molecule 1 (anti-STIM1) rabbit
IgG (Santa Cruz) and anti-phosphatidylinositol 4,5-bisphosphate
(anti-PIP2) mouse IgG (Santa Cruz), for 3 h at RT. The secondary
antibodies conjugated with oligonucleotide plus or minus probes
were diluted with 10% bovine serum in PBS and then added to
the cells after washing twice in Tris-buffered saline containing
Tween 20. Cells were incubated for 1 h at 37 C. After probe
hybridization, the cells were washed twice with wash buffer A,
supplied in the Duolink kit, and then incubated in a solution con-
taining ligase for 30 min at 37 C. After washing again, polymerase
was added to the ampliﬁcation solution and then incubated for 1 h
40 min at 37 C. Cells were then washed twice in wash buffer B
from the kit. Nuclei were counterstained with 40,6-diamidino-2-
phenylindole (DAPI), and then images were obtained using an
LSM700 confocal microscope (Carl Zeiss) and analyzed using the
Duolink ImageTool (Sigma).
2.6. siRNA transfection and quantitative real-time PCR
siRNA transfection was conducted with Lipofectamine
RNAiMAX Reagent (Invitrogen), according to the manufacturer’s
instructions. Cells were seeded at the density of 1  106 cells inllular calcium in MDA-MB-468 cells. (A) Phosphorylated ERK in the cytoplasmic
Structure of the ERK2/PEA-15 complex and schematic illustration of PEA-15 mutant
terminal tail. The mutated leucine 123 located at the C-terminal tail is indicated in
crease the phosphorylation of ERK. (D) Treatment with Fluo-4 AM calcium indicator
s were obtained by confocal microscopy with the 20 object using appropriate
uantitation of ﬂuorescence signals from Fig. 2D using Duolink ImageTool (Sigma).
01).
Fig. 3. EGFR and PTP1B co-localization in ER–PM contacts. (A) Schematic representation of proximal ligation assay (PLA) assay. (B) Fluorescence images from PLA assay using
STIM1 and PIP2 antibodies after PEA-15 transfection. Red ﬂuorescence signals indicate ER–PM contact sites (left) observed with confocal microscopy under 60 object. Scale
bar, 5 lm. (C) Cellular images of MDA-MB-468 cells transfected with PEA-15::pCDNA3.1 (PEA-15) or empty vector (Mock) for 48 h and counterstained with DAPI (blue) for
nuclei. Alexa Flour 488-conjugated antibody against EGFR was used for EGFR imaging (green) and anti-rabbit conjugated rhodamine secondary antibody was used for anti-
PTP1B (red). Scale bar, 10 lm.
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ence. Cells were transfected with 10 nM siRNAs for the PEA-15
and PTP1B genes, with scrambled siRNA as a control (Santa Cruz)
for 48 h. Each 1 lg sample of total RNA from the siRNA-treated
MDA-MB-468 cells was reverse-transcribed using PrimeScript™ II
1st strand cDNA Synthesis Kit (TaKaRa), according to the manufac-
turer’s instructions. Quantitative real-time PCR was conducted on a
7500 Real-Time PCR System (Applied Biosystems) using the SYBR
green detection protocol.
2.7. Intracellular calcium measurement
For confocal imaging, cells were loaded with 5 lM ﬂou-4 AM
(Invitrogen) for 30 min and then washed, after which images were
obtained using an LSM700 confocal microscope (Carl Zeiss) and
analyzed using the Duolink ImageTool (Sigma).
2.8. Immunoﬂuorescence assay
Cells were seeded at a density of 1.0  105 cells in 35 mm cov-
erglass-bottomed dishes (SPL Life Sciences) and incubated for 24 h.
Cells were ﬁxed with ice-cold 100% methanol for 20 min at 20 C
and then washed twice with PBS. Fixed cells were incubated for 1 h
at RT in 10% bovine serum diluted in PBS, and then with the
primary antibodies for 3 h at RT. Alexa Fluor Dye-conjugated
anti-rabbit or anti-mouse IgG (Molecular Probes) were used asthe secondary antibodies and incubated with the cells for 1 h.
After the cells were washed, nuclei were counterstained using
DAPI. Images were obtained using an LSM700 Confocal microscope
(Carl Zeiss).
2.9. Statistical analysis
In vitro results were expressed as the mean ± standard devia-
tion (S.D.). All results were analyzed by Prism version 5
(GraphPad software) using the Student’s t-test.
3. Results and discussion
3.1. PEA-15 affects the cell viability and phosphorylation of EGFR in
TNBC cell lines
PEA-15 is a phosphor-enriched protein that was recently
reported as having tumor-suppressive function in TNBC cells
[12,22]. Herein, cell viability was ﬁrst checked using the MTS assay
after PEA-15 transfection in three TNBC cell lines, MDA-MB-468,
-231, and -436. All three cell lines showed decreased cell viability,
while the MDA-MB-468 cells showed relatively less viability than
the other two types (Fig. 1A). Due to the absence of hormonal
receptors in TNBC cell lines, the level of EGFR expression has been
considered as an important factor for regulatory cell fate and as a
therapeutic target for TNBC treatment [23,24]. To investigate the
Fig. 4. A mechanism of EGFR down regulation via ER–PM contacts. (A) Gel image was obtained from cDNA ampliﬁcation after treatment with siRNA for the PTP1B gene
(PTP1B siRNA) or scrambled siRNA (Scram siRNA) as a control. The graph indicates the relative expression of PTP1B transcripts after quantitative RT-PCR with primers speciﬁc
for PTP1B (Forward; 50 GCAGATCGACAAG TCCGGG-30 , Reverse; 50-GCCCTGGGTAAGAATGTAACTCC-30) and GAPDH for normalization. (B) Immunoblot analysis performed with
anti-pEGFR, anti-EGFR, anti-PEA-15 and anti-PTP1B after treatment with PTP1B siRNA or scrambled siRNA control carried out in MDA-MB-468 cells transfected with PEA-15
(+) or empty vector (). (C) Subcellular fractionation of MDA-MB-468 cells was performed using ProteoExtract Subcellular Proteome Extraction Kit (Merck), according to the
manufacturer’s instructions, and immunoblot analysis was performed with anti-PTP1B and anti-PEA-15. (D) A schematic diagram of the mechanisms of EGFR down-
regulation through calcium-dependent ER–PM contacts in response to cytoplasmic signaling of phosphorylated ERK due to PEA-15. Blue arrows indicate signaling pathways.
The exact molecular basis for the increased intracellular calcium concentration by the sequestration of pERK in the cytoplasm is not yet fully understood, and thus indicated
as a dotted arrow. The green arrow indicates the enhancement of intracellular calcium concentration.
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cell lines, the levels of EGFR expression were examined following
the exogenous expression of PEA-15. The three TNBC cell lines
examined showed different levels of EGFR expression, and the
overexpression of PEA-15 in the three lines did not result in any
difference of their endogenous levels of EGFR whether PEA-15
was transfected (+) or not () (Fig. 1B). However, the level of acti-
vated/phosphorylated EGFR was decreased after transfection with
PEA-15 in two of the TNBC cell lines: MDA-MB-468, having high
levels of EGFR expression, and MDA-MB-436, having low EGFR
expression (Fig. 1C). These results indicate that the attenuation of
phosphorylated EGFR was correlated with the exogenous expres-
sion of PEA-15 in TNBC cells. Also, in consideration of the report
that PEA-15 inhibited tumor invasion and cell migration in breast
tumor cells [6], the wound healing assay was carried out herein.
The results indicated decreased cell migration of PEA-15-express-
ing TNBC cells after making a scratch wound in mono-layered cells
(Fig. 1D). In order to conﬁrm whether or not these effects were due
to the overexpression of PEA-15, the PEA-15 gene was silenced
using siRNA for PEA-15 (Fig. 1E), after which less phosphorylation
of ERK was observed after EGF treatment in MDA-MB-468 cells(Fig. 1F). This result conﬁrmed the involvement of PEA-15 in the
EGFR pathway, and led us to look into the ERK interaction.
3.2. PEA-15 sequesters pERK and induces the enhancement of
intracellular calcium concentration
The cytoplasmic retention of ERK has been considered as an
important regulatory signaling mechanism in breast cancer due to
PEA-15 sequestration [7,25]. Furthermore, structural study of the
PEA-15/ERK2 complex provides insight into the tumor suppressive
role of PEA-15 as an inhibitory factor of ERK2 dephosphorylation
[5]. It was conﬁrmed herein after cellular fractionation that the
phosphorylated ERK was retained in the cytoplasm with PEA-15.
PEA-15 expression increased the presence of cytoplasmic, phos-
phorylated ERK in MDA-MB-468 cells (Fig. 2A). In order to conﬁrm
direct interaction with ERK, a blocking L123K mutant was con-
structed using site-directed mutagenesis based on the previous
structural study [5]. A hydrophobic leucine residue was replaced
with a positively charged lysine in the ERK binding region of PEA-
15 (Fig. 2B). Immunoblot analysis of the fractionated cytoplasmic
compartment clearly showed that ERK phosphorylation was less
1038 M. Shin et al. / FEBS Letters 589 (2015) 1033–1039affected by PEA-15 L123K (Fig. 2C), because the mutation inhibited
the binding of PEA-15 to ERK. Importantly, modulation of the spa-
tial distribution of ERK can change the downstream signaling to
immediate early genes, and is correlated with the complex mecha-
nism of carcinogenesis [19]. The duration of ERK signaling can also
be affected by activated phosphatases from calcium inﬂux [20].
From observations, the PEA-15 transfected MDA-MB-468 cells
appeared to have lost adherence to the culture dish. Metastatic
dissemination is one of the initial hallmarks of cancer and is often
impossible to eliminate [26], while the intracellular Ca2+ concen-
tration is known to be involved in cell migration as a ubiquitous
second messenger [27]. Hence, the intracellular calcium concentra-
tion was examined in the PEA-15 expressing MDA-MB-468 cells,
one of the metastatic TNBC cell lines. The Fluo-4 acetoxymethyl
ester (Fluo-4 AM) calcium indicator translated increased intra-
cellular Ca2+ concentration to ﬂuorescence signals (Fig. 2D). ns an
ubiquitous second messengers of cell migration and the intra-
cellular Ca2+ concentration have been known to be involved
Measurement of the elevated ﬂuorescent signal obtained from con-
focal microscopy images demonstrated that cells transfected with
PEA-15 WT had higher amounts of calcium than both mock and
L123K mutant transfected cells. Image analysis by Duolink
ImageTool (Sigma) showed that the intracellular calcium signals
of PEA-15-expressing cells were increased by approximately
3 times in comparison with the mock-treated cells, and 2 times
compared with the PEA-15 L123K transfected cells (Fig. 2E).
3.3. PEA-15 affects the dephosphorylation of EGFR by PTP1B at the ER–
PM contacts induced by increased calcium concentration
STIM proteins are the ER-localized luminal sensors for store-
operated Ca2+ entry, and STIM1 can directly interact with PM
PIP2 lipids to enhance the formation of the ER–PM junction, as well
as to induce store-operated Ca2+ inﬂux into cells by PM-localized
Ca2+ channels [28,29]. Based on the previous reports, the interac-
tion between STIM1 and PIP2 was investigated after PEA-15 trans-
fection to examine the inﬂuence on MDA-MB-468 cells, possibly
induced by change of the intracellular calcium concentration due
to sequestration of pERK. Using PLA, as described schematically
in Fig. 3A, the speciﬁc protein–protein interaction in the endoge-
nous expression level was veriﬁed. The increased red ﬂuorescence
signals demonstrated that PEA-15 expression triggered the interac-
tion between STIM1 and PIP2, likely due to increase of the intra-
cellular calcium concentration (Fig. 3B).
The ER-anchored protein tyrosine phosphatase PTP1B functions
at ER–PM junctions as well, and EGFR has been identiﬁed as one of
the potential substrates for PTP1B [30]. Activated and internalized
EGFR is dephosphorylated by PTP1B at ER-endosome membrane
contact sites, which is necessary for EGFR down-regulation [31].
This mechanism of EGFR was reported through imaging of the
direct contact of immuno-labeled EGFR and PTP1B in human can-
cer cells [32], and direct membrane contacts between the perime-
ter membrane of multivesicular bodies and the ER have already
been reported through electron microscopy images [15].
However, the search for proteins which act as critical factors for
the connection of the ER–PM contacts is still in process. Based on
our observations of the cytoplasmic localization of EGFR in PEA-
15 transfected cells, the subcellular localization of endogenous
EGFR was obviously altered to move out of the plasma membrane,
as it was merged with the ER-localized PTP1B in MDA-MB-468
cells (Fig. 3C). Since induction of the dephosphorylation of EGFR
in these cells by PEA-15 expression was already observed in
Fig. 1C, we examined whether this mechanism of EGFR down-
regulation was correlated with phosphatase PTP1B. Knockdown
of PTP1B using siRNA treatment (Fig. 4A) demonstrated that the
phosphorylation of EGFR was retained, regardless of mock () orPEA-15 (+) transfection, when PTP1B was silenced (Fig. 4B). The
immunoblot of subcellular fractionation indicated that PTP1B stays
localized in the membrane and organelle compartment after
PEA-15 transfection (Fig. 4C).
In summary, we described herein the signaling pathway linking
the overexpression of PEA-15 to the dephosphorylation of EGFR
(Fig. 4D), for which down-regulation of EGFR signaling in TNBC
cells has been suggested to be correlated with the tumor suppres-
sive function of PEA-15. This must be particularly important in cer-
tain types of cancer that are known to involve the EGFR signaling
pathway. The results presented here explain that PEA-15 can act
as a potential tether for junction of the intracellular signaling in
a TNBC cell line, and we provide the ﬁrst evidence that PEA-15
affects EGFR dephosphorylation through ER–PM contacts.Acknowledgements
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